Alpha Cognition Inc. (ACOGF)
USD 5.73
(N/A%)
USD 5.73
(N/A%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.77 Million USD | -13.68% |
| 2022 | -12.11 Million USD | 38.02% |
| 2021 | -19.54 Million USD | -237.9% |
| 2020 | -5.78 Million USD | 12.45% |
| 2019 | -6.6 Million USD | -20254.71% |
| 2018 | -32.45 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2.11 Million USD | 57.49% |
| 2024 Q1 | -4.97 Million USD | 14.16% |
| 2023 Q1 | -1.86 Million USD | 54.84% |
| 2023 FY | -14.01 Million USD | -15.69% |
| 2023 Q2 | -2.79 Million USD | -49.92% |
| 2023 Q4 | -5.79 Million USD | -74.44% |
| 2023 Q3 | -3.32 Million USD | -19.08% |
| 2022 Q2 | -3 Million USD | -3.11% |
| 2022 Q1 | -2.91 Million USD | 7.5% |
| 2022 Q4 | -4.12 Million USD | -98.65% |
| 2022 FY | -12.11 Million USD | 38.02% |
| 2022 Q3 | -2.07 Million USD | 30.91% |
| 2021 FY | -19.54 Million USD | -237.9% |
| 2021 Q2 | 149.21 Thousand USD | 101.22% |
| 2021 Q1 | -12.22 Million USD | -9764.69% |
| 2021 Q4 | -3.14 Million USD | 26.56% |
| 2021 Q3 | -4.28 Million USD | -2974.43% |
| 2020 Q4 | -123.92 Thousand CAD | -57.2% |
| 2020 Q3 | -78.83 Thousand USD | 0.0% |
| 2020 FY | -5.78 Million USD | 12.45% |
| 2019 Q4 | -6552.50 CAD | 37.31% |
| 2019 FY | -6.6 Million USD | -20254.71% |
| 2019 Q3 | -10.45 Thousand USD | 0.0% |
| 2018 FY | -32.45 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | -931.32% |
| Arch Therapeutics, Inc. | -6.98 Million USD | -97.235% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 125.996% |
| Nascent Biotech, Inc. | -2.08 Million USD | -559.706% |
| Rebus Holdings, Inc. | -1.02 Million USD | -1250.252% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 121.145% |
| Qrons Inc. | -789.34 Thousand USD | -1644.805% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -2077.801% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 77.999% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -3214.865% |
| Skye Bioscience, Inc. | -37.64 Million USD | 63.414% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 81.628% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | -109.433% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -4937.479% |
| SQZ Biotechnologies Company | -79.46 Million USD | 82.668% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | -376.165% |
| Propanc Biopharma, Inc. | -1.82 Million USD | -656.515% |
| Mesoblast Limited | -87.95 Million USD | 84.342% |
| Marizyme, Inc. | -65.34 Million USD | 78.924% |
| Genus plc | 7.9 Million USD | 274.336% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | -26.45% |
| Pharming Group N.V. | -10.54 Million USD | -30.57% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | -534.735% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | -271.205% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | -55.728% |
| ContraFect Corporation | -65.15 Million USD | 78.861% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | -181.875% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | -697.275% |
| IMV Inc. | -36.48 Million USD | 62.252% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | -70.882% |
| MultiCell Technologies, Inc. | -380.07 USD | -3623592.215% |
| ONE Bio Corp. | 8.67 Million USD | 258.732% |
| Accustem Sciences Inc. | -3.74 Million USD | -267.62% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 73.356% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -986.907% |
| Q BioMed Inc. | -2.05 Million USD | -571.147% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | -268.941% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | -478.468% |
| Biomind Labs Inc. | -1.21 Million USD | -1034.18% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 76.94% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | -344.023% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | -74.268% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | -606.558% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -91864.256% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 13.224% |
| Curative Biotechnology, Inc. | -5.81 Million USD | -136.754% |
| GB Sciences, Inc. | -1.36 Million USD | -911.442% |
| HST Global, Inc. | -146.21 Thousand USD | -9319.716% |
| CSL Limited | 2.64 Billion USD | 100.521% |
| Wesana Health Holdings Inc. | -1.75 Million USD | -684.864% |
| Halberd Corporation | -79.67 Thousand USD | -17185.716% |
| Enzolytics Inc. | -2.17 Million USD | -532.689% |
| Agentix Corp. | -1.37 Million USD | -902.216% |
| Resverlogix Corp. | -3.61 Million USD | -281.512% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | -334.269% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 95.332% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 14153.64% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 298.893% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | -246.655% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | -355.121% |
| AVAX Technologies, Inc. | -6.41 Million USD | -114.738% |
| Zenith Capital Corp. | -10.59 Million USD | -29.979% |
| Genscript Biotech Corporation | -95.47 Million USD | 85.575% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -59157.237% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | -232.194% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -22686.942% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -586.872% |
| Kadimastem Ltd | -3.3 Million USD | -316.417% |
| Helix BioMedix, Inc. | -1.05 Million USD | -1204.15% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | -260.633% |
| BioStem Technologies, Inc. | -8.48 Million USD | -62.355% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -3020.42% |
| LadRx Corporation | 400.44 Thousand USD | 3539.333% |
| Cell Source, Inc. | -5.32 Million USD | -158.824% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1445.624% |
| Regen BioPharma, Inc. | 1.02 Million USD | 1445.624% |
| NovAccess Global Inc. | -4.76 Million USD | -188.782% |
| Affymax, Inc. | -14.42 Million USD | 4.516% |
| Itoco Inc. | -1.86 Million USD | -636.897% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | -210.016% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | -725.199% |
| Mobile Lads Corp. | -2.26 Million USD | -508.519% |
| CytoDyn Inc. | -49.84 Million USD | 72.367% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -17326.35% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -5937.237% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -1362.787% |
| SYBLEU INC | -180.3 Thousand USD | -7538.525% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -753.987% |
| International Stem Cell Corporation | -131 Thousand USD | -10413.41% |
| Bioxytran, Inc. | -4.28 Million USD | -221.789% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -25276.929% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | -444.317% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 71.35% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | -551.493% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -1663.708% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | -334.74% |
| Neutra Corp. | -233.46 Thousand USD | -5799.2% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 32.125% |
| PureTech Health plc | -65.69 Million USD | 79.036% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 35.238% |
| IXICO plc | -1.17 Million USD | -1069.148% |
| IntelGenx Technologies Corp. | -9.92 Million USD | -38.738% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 75.892% |
| CSL Limited | 2.64 Billion USD | 100.521% |
| Cellectis S.A. | -103.17 Million USD | 86.651% |